Kailera Therapeutics, Inc. (KLRA)
16.54
-0.63
(-3.67%)
USD |
NASDAQ |
Aug 24, 16:00
16.54
0.00 (0.00%)
After-Hours: 20:00
Kailera Therapeutics EPS Diluted (Quarterly) : -0.8587 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.8587 |
| March 31, 2026 | -0.6087 |
| Date | Value |
|---|---|
| June 30, 2025 | -0.2233 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Moderna, Inc. | -1.965 |
| Revolution Medicines, Inc. | -3.055 |
| Sana Biotechnology, Inc. | -0.2152 |
| Parabilis Medicines, Inc. | -0.5421 |
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -111.31M |
| Total Expenses (Quarterly) | 111.31M |
| Enterprise Value | 1.319B |
| Earnings Yield | -10.22% |